Evaluating Circulating Tumor DNA to Predict Overall Survival Risk in Non-Squamous Non-Small Cell Lung Cancer in IMpower150

被引：0
|
作者：
Assaf, Z. J. [1 ]
Fine, A. [2 ]
Zou, W. [1 ]
Socinski, M. [3 ]
Young, A. [2 ]
Freidin, J. [2 ]
Kennedy, M. [2 ]
Polisecki, E. [2 ]
Nishio, M. [4 ]
Oxnard, G. [2 ]
Cummings, C. [1 ]
Rode, A. [5 ]
Reck, M. [6 ]
Patil, N. [1 ]
Shames, D. [1 ]
Schulz, K. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Fdn Med Inc, Cambridge, MA USA
[3] Adventhlth Canc Inst, Orlando, FL USA
[4] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[5] F Hoffman La Roche Ag, Basel, Switzerland
[6] German Ctr Lung Res, Lungenclin Grosshansdorf, Airway Res Ctr North, Grosshansdorf, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
predictive biomarker; ctDNA variant clearance; surrogate endpoint for survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA07.02
引用
收藏
页码：S905 / S906
页数：2
相关论文
共 50 条
  • [1] CARBOPLATIN AND PEMETREXED FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - OVERALL SURVIVAL AND TOXICITY
    Andersen, R.
    Mellemgaard, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S73 - S73
  • [2] Atezolizumab, Bevacizumab and Chemotherapy (IMpower150) in Stage IV Non-Small Cell Lung Cancer: The Australian Experience
    Dean, S.
    Ainsworth, H.
    Alexander, M.
    Dharmaraj, D.
    O'Connell, R.
    Mitchell, P.
    Torres, J.
    Saqib, A.
    Ladwa, R.
    Pavlakis, N.
    Clarke, S.
    Tay, R.
    Solomon, B.
    John, T.
    Moore, M.
    Yip, P. Y.
    Kao, S.
    Itchins, M.
    Parakh, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1015 - S1016
  • [3] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
  • [4] Association of comprehensive molecular genotyping and overall survival in patients with advanced non-squamous non-small cell lung cancer.
    Aggarwal, Charu
    Marmarelis, Melina Elpi
    Hwang, Wei-Ting
    Scholes, Dylan G.
    McWilliams, Tara
    Singh, Aditi Puri
    Sun, Lova
    Kosteva, John A.
    Costello, Michael Robert
    Cohen, Roger B.
    Langer, Corey J.
    Gabriel, Peter Edward
    Shulman, Lawrence N.
    Thompson, Jeffrey C.
    Carpenter, Erica L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.
    Jee, Justin
    Lebow, Emily S.
    Murciano-Goroff, Yonina R.
    Jayakumaran, Gowtham
    Shen, Ronglai
    Brannon, Angela Rose
    Benayed, Ryma
    Namakydoust, Azadeh
    Offin, Michael
    Paik, Paul K.
    Yu, Helena Alexandra
    Donoghue, Mark
    Zehir, Ahmet
    Drilon, Alexander E.
    Solit, David B.
    Jones, David Randolph
    Rudin, Charles M.
    Berger, Michael F.
    Isbell, James M.
    Li, Bob T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    [J]. LANCET, 2021, 397 (10274): : 557 - 559
  • [7] Circulating Tumor DNA Assay and Survival in Patients with Metastatic, Non-Small Cell Lung Cancer
    Ersek, J.
    Hosking, M.
    Symanowski, J.
    Green, E.
    Zhang, Q.
    Kim, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S663 - S664
  • [8] Integrated analysis of randomized controlled trials IMpower130 and IMpower132 for advanced non-squamous non-small cell lung cancer (NSCLC)
    Nishio, M.
    Watanabe, S.
    Udagawa, H.
    Aragane, N.
    Nakagawa, Y.
    Kobayashi, Y.
    Saito, H.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1681 - S1681
  • [9] Detection and application of circulating tumor cell and circulating tumor DNA in the non-small cell lung cancer
    Zhang, Yuting
    Zheng, Hongmei
    Zhan, Yuting
    Long, Mengping
    Liu, Sile
    Lu, Junmi
    Zang, Hongjing
    Fan, Songqing
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (12): : 2377 - 2386
  • [10] Circulating T cell subpopulations correlate with immune inflammatory signatures at the tumor site in melanoma and non-squamous non-small cell lung cancer
    Manjarrez-Orduno, Nataly
    Kansal, Selena
    Menard, Laurence
    Lezhnin, Sergey
    Jiang, Can
    Kayne, Paul
    Edwards, Robin
    Suchard, Suzanne
    Fischer, Paul
    Kakrecha, Bijal
    Yu, Chiang
    Carman, Julie
    Dai, Hongyue
    Bernstein, Steven
    Nadler, Steven
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345